| 24/04/26 | 15:16:17 | 24 Apr 2026 | | Posting of Annual Report & Notice of AGM |
| 13/04/26 | 07:00:06 | 13 Apr 2026 | | Results for the year ended 31 December 2025 |
| 07/04/26 | 07:01:00 | 7 Apr 2026 | | Notice of Results |
| 07/04/26 | 07:00:11 | 7 Apr 2026 | | Appointment of Nominated Adviser and Joint Broker |
| 01/04/26 | 07:00:08 | 1 Apr 2026 | | Block Listing Return |
| 11/03/26 | 07:00:11 | 11 Mar 2026 | | Monument Therapeutics MT1988 First Patient Dosed |
| 16/02/26 | 07:00:05 | 16 Feb 2026 | | Commercialisation Agreement |
| 09/02/26 | 07:00:10 | 9 Feb 2026 | | Change of Joint Broker |
| 19/01/26 | 07:00:04 | 19 Jan 2026 | | Trading Update |
| 05/11/25 | 07:01:01 | 5 Nov 2025 | | Change of Auditor |
| 05/11/25 | 07:00:11 | 5 Nov 2025 | | Board Updates |
| 01/10/25 | 07:00:15 | 1 Oct 2025 | | Block Listing Return |
| 29/09/25 | 07:00:15 | 29 Sept 2025 | | Exercise of Options and Total Voting Rights |
| 26/09/25 | 09:59:32 | 26 Sept 2025 | | Holding(s) in Company |
| 08/09/25 | 07:00:10 | 8 Sept 2025 | | Holding(s) in Company |
| 05/09/25 | 14:51:10 | 5 Sept 2025 | | Holding(s) in Company |
| 05/09/25 | 12:04:40 | 5 Sept 2025 | | Holding(s) in Company |
| 02/09/25 | 17:21:47 | 2 Sept 2025 | | Holding(s) in Company |
| 01/09/25 | 10:58:52 | 1 Sept 2025 | | Investor Presentation via Investor Meet Company |
| 28/08/25 | 10:45:01 | 28 Aug 2025 | | £1.12m Placing & Subscription, TVR & PDMR Dealings |
| 28/08/25 | 07:01:01 | 28 Aug 2025 | | Changes to Board and Management |
| 28/08/25 | 07:00:09 | 28 Aug 2025 | | Interim Results |
| 19/08/25 | 10:10:03 | 19 Aug 2025 | | Monument Therapeutics Partnership with FNIH |
| 12/08/25 | 07:00:04 | 12 Aug 2025 | | Launch of Speaker Identification Solution |
| 31/07/25 | 07:00:13 | 31 Jul 2025 | | Trading update for period ended 30 June 2025 |
| 27/06/25 | 12:27:30 | 27 Jun 2025 | | Result of AGM |
| 24/06/25 | 07:00:10 | 24 Jun 2025 | | Monument Therapeutics Success in Phase I Results |
| 04/06/25 | 07:00:10 | 4 Jun 2025 | | Notice of AGM |
| 06/05/25 | 17:59:49 | 6 May 2025 | | Holding(s) in Company |
| 01/05/25 | 07:00:07 | 1 May 2025 | | Preliminary Unaudited Results |
| 24/04/25 | 07:00:13 | 24 Apr 2025 | | Notice of Results and Investor Presentation |
| 10/04/25 | 07:00:05 | 10 Apr 2025 | | Contract Win |
| 07/04/25 | 10:24:29 | 7 Apr 2025 | | Holding(s) in Company |
| 03/04/25 | 07:00:07 | 3 Apr 2025 | | Contract Win |
| 01/04/25 | 07:00:12 | 1 Apr 2025 | | Block Listing Return |
| 06/03/25 | 07:00:15 | 6 Mar 2025 | | CANTAB® used for major global brain health study |
| 18/02/25 | 07:00:08 | 18 Feb 2025 | | Cambridge Cognition submits FDA Letter of Intent |
| 07/02/25 | 07:00:07 | 7 Feb 2025 | | Board Appointment |
| 21/01/25 | 07:00:06 | 21 Jan 2025 | | Launch of in-house rater training service |
| 16/01/25 | 07:00:05 | 16 Jan 2025 | | Expanded partnership with Actinogen |
| 08/01/25 | 07:00:06 | 8 Jan 2025 | | CANTAB® success in Bristol Myers Squib research |
| 27/12/24 | 15:34:53 | 27 Dec 2024 | | Director/PDMR Share Purchases |
| 23/12/24 | 16:02:43 | 23 Dec 2024 | | Director/PDMR Share Purchases |
| 16/12/24 | 09:20:13 | 16 Dec 2024 | | Director/PDMR Share Purchases |
| 10/12/24 | 07:00:04 | 10 Dec 2024 | | Trading Update |
| 18/11/24 | 16:02:37 | 18 Nov 2024 | | Holding(s) in Company |
| 06/11/24 | 07:00:07 | 6 Nov 2024 | | Monument Therapeutics secures £1m investment |
| 31/10/24 | 07:00:10 | 31 Oct 2024 | | New data demonstrates effectiveness of AQUA |
| 18/10/24 | 07:00:05 | 18 Oct 2024 | | Directorate Change |
| 10/10/24 | 12:44:20 | 10 Oct 2024 | | Block Listing Return |
